Research News and Research

RSS

Patients with implanted cardiac devices can safely drive or ride in electric cars without risk of EMI

A Mayo Clinic study has concluded that patients with implanted cardiac devices such as pacemakers and defibrillators can safely drive or ride in an electric car without risk of electromagnetic interference (EMI).

11 Mar 2013

U.N. warns of little progress curbing child marriage rates; Human Rights Watch report shows practice widespread in South Sudan

"If current child marriage rates continue, more than 140 million girls will become child brides between 2011 and 2020, the United Nations said [Thursday], warning that little progress has been made towards ending this harmful practice," the U.N. News Centre reports.

11 Mar 2013

Armetheon plans to develop tecarfarin against prosthetic heart valves or chronic renal dysfunction

Armetheon, Inc., a clinical stage biopharmaceutical company, announced today that it plans to develop its novel oral anti-coagulant (OAC), tecarfarin (ATI-5923), for a patient population which includes those who have prosthetic heart valves or chronic renal dysfunction.

11 Mar 2013

Obesity during pregnancy linked with increased risk of frequent wheezing in children

The fact that excess weight during pregnancy has negative consequences is not new information. A new study now concludes that the children of mothers obese before falling pregnant are four times more likely to have frequent wheezing, which is one of the symptoms of asthma, compared to the children of mothers weighing a normal weight.

11 Mar 2013

Drugs that combat ageing may be available within five years

Drugs that combat ageing may be available within five years, following landmark work led by an Australian researcher.

11 Mar 2013

Planar cell polarity genes control connectivity of enteric neurons

The enteric nervous system (ENS), the "little brain" that resides within the gut wall, governs motility, secretion, and blood flow in the human gastrointestinal tract. Failure of the ENS to develop normally leads to congenital megacolon (Hirschsprung Disease) while loss of normal gut innervation is thought to contribute to debilitating motility disorders, such as irritable bowel syndrome.

11 Mar 2013

Inclacumab reduces damage to heart muscle during angioplasty

A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial spearheaded by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, affiliated with the University of Montreal.

11 Mar 2013

Viewpoints: Congress should make CMS leader nonpartisan position; 'Extreme' attack on abortion in Arkansas; Daschle on new health workforce

Mr. Obama has nominated the acting CMS administrator, Marilyn Tavenner, to head the agency permanently. ... The Senate should move expeditiously to confirm Ms. Tavenner. More broadly, Congress should consider whether short-term political appointment remains the best way to fill this trillion-dollar post. The director of the Federal Bureau of Investigation serves a 10-year term.

11 Mar 2013

Cell fusion studies at Johns Hopkins could lead to improved treatments for muscular dystrophy

Researchers at Johns Hopkins have established a high-efficiency cell-cell fusion system, providing a new model to study how fusion works. The scientists showed that fusion between two cells is not equal and mutual as some assumed, but, rather, is initiated and driven by one of the fusion partners. The discovery, they say, could lead to improved treatments for muscular dystrophy, since muscle regeneration relies on cell fusion to make muscle fibers that contain hundreds or even thousands of nuclei.

8 Mar 2013

Cardiovascular disease risk in women higher than you think

In conjunction with International Women's Day, the European Cardiology Society reminds women that they may be at a greater risk for cardiovascular disease (CVD) than they think.

8 Mar 2013

Investigational treatment for ulcerative colitis (UC) and Crohn’s disease (CD) has Marketing Authorisation Application submitted

Takeda Pharmaceutical Company Limited (“Takeda”) today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn’s disease (CD), the two most common types of inflammatory bowel disease (IBD).

8 Mar 2013

Research News and Research

Patients with implanted cardiac devices can safely drive or ride in electric cars without risk of EMI

U.N. warns of little progress curbing child marriage rates; Human Rights Watch report shows practice widespread in South Sudan

Armetheon plans to develop tecarfarin against prosthetic heart valves or chronic renal dysfunction

Obesity during pregnancy linked with increased risk of frequent wheezing in children

Drugs that combat ageing may be available within five years

Planar cell polarity genes control connectivity of enteric neurons

Inclacumab reduces damage to heart muscle during angioplasty

Viewpoints: Congress should make CMS leader nonpartisan position; 'Extreme' attack on abortion in Arkansas; Daschle on new health workforce

Cell fusion studies at Johns Hopkins could lead to improved treatments for muscular dystrophy

Cardiovascular disease risk in women higher than you think

Investigational treatment for ulcerative colitis (UC) and Crohn’s disease (CD) has Marketing Authorisation Application submitted

Animal robots help treat dementia

Artificial pancreas outperforms insulin pump in diabetes camp

AKAP protein alterations implicated in bipolar disorder

Inflammatory marker for schizophrenia treatment resistance, severity

Pharmacist-led intervention combats hypertension

Experience shows in febrile neutropenia treatment

Marked seasonal variation in COPD exacerbations

Global cancer problem ‘needs international solution’

Researchers uncover cellular-level detail of what happens when bone bears stress over time

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery